BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30499198)

  • 1. Atherectomy in below-the-knee endovascular interventions: One-year outcomes from the XLPAD registry.
    Khalili H; Jeon-Slaughter H; Armstrong EJ; Baskar A; Tejani I; Shammas NW; Prasad A; Abu-Fadel M; Brilakis ES; Banerjee S
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):488-493. PubMed ID: 30499198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of lesion location on procedural and acute angiographic outcomes in patients with critical limb ischemia treated for peripheral artery disease with orbital atherectomy: A CONFIRM registries subanalysis.
    Lee MS; Mustapha J; Beasley R; Chopra P; Das T; Adams GL
    Catheter Cardiovasc Interv; 2016 Feb; 87(3):440-5. PubMed ID: 26649816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia.
    Todd KE; Ahanchi SS; Maurer CA; Kim JH; Chipman CR; Panneton JM
    J Vasc Surg; 2013 Oct; 58(4):941-8. PubMed ID: 23755978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid state, pulsed-wave 355 nm UV laser atherectomy debulking in the treatment of infrainguinal peripheral arterial disease: The Pathfinder Registry.
    Das TS; Shammas NW; Yoho JA; Martinez-Clark P; Ramaiah V; Leon LR; Pacanowski JP; Tai Z; Ali V; Arslan B; Rundback J
    Catheter Cardiovasc Interv; 2024 May; 103(6):949-962. PubMed ID: 38566525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stent and Non-Stent Based Outcomes of Infrainguinal Peripheral Artery Interventions From the Multicenter XLPAD Registry.
    Banerjee S; Pershwitz G; Sarode K; Mohammad A; Abu-Fadel MS; Baig MS; Tsai S; Little BB; Gigliotti OS; Soto-Cora E; Foteh MI; Rodriguez G; Klein A; Addo T; Luna M; Shammas NW; Prasad A; Brilakis ES
    J Invasive Cardiol; 2015 Jan; 27(1):14-8. PubMed ID: 25589695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study.
    Zeller T; Langhoff R; Rocha-Singh KJ; Jaff MR; Blessing E; Amann-Vesti B; Krzanowski M; Peeters P; Scheinert D; Torsello G; Sixt S; Tepe G;
    Circ Cardiovasc Interv; 2017 Sep; 10(9):e004848. PubMed ID: 28916599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser Atherectomy Combined With Drug-Coated Balloon Angioplasty Is Associated With Improved 1-Year Outcomes for Treatment of Femoropopliteal In-Stent Restenosis.
    Kokkinidis DG; Hossain P; Jawaid O; Alvandi B; Foley TR; Singh GD; Waldo SW; Laird JR; Armstrong EJ
    J Endovasc Ther; 2018 Feb; 25(1):81-88. PubMed ID: 29219030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-Year Outcomes Following Directional Atherectomy of Popliteal Artery Lesions: Subgroup Analysis of the Prospective, Multicenter DEFINITIVE LE Trial.
    Rastan A; McKinsey JF; Garcia LA; Rocha-Singh KJ; Jaff MR; Harlin S; Kamat S; Janzer S; Zeller T
    J Endovasc Ther; 2018 Feb; 25(1):100-108. PubMed ID: 29117818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.
    Foley TR; Cotter RP; Kokkinidis DG; Nguyen DD; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2017 May; 89(6):1078-1085. PubMed ID: 28295971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
    Stavroulakis K; Schwindt A; Torsello G; Stachmann A; Hericks C; Bosiers MJ; Beropoulis E; Stahlhoff S; Bisdas T
    J Endovasc Ther; 2017 Apr; 24(2):181-188. PubMed ID: 28008792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pooled analysis of the CONFIRM registries: impact of gender on procedure and angiographic outcomes in patients undergoing orbital atherectomy for peripheral artery disease.
    Lee MS; Canan T; Rha SW; Mustapha J; Adams GL
    J Endovasc Ther; 2015 Feb; 22(1):57-62. PubMed ID: 25775681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Outcomes and Cost Comparisons of Stent and Non-Stent Interventions in Infrainguinal Peripheral Artery Disease: Insights From the Excellence in Peripheral Artery Disease (XLPAD) Registry.
    Banerjee S; Jeon-Slaughter H; Armstrong EJ; Bajzer C; Abu-Fadel M; Khalili H; Prasad A; Bou Dargham B; Kamath P; Addo T; Luna M; Gigliotti O; Foteh M; Cawich I; Kinlay S; Ali M; Ramanan B; Niazi K; Tsai S; Shammas NW; Brilakis ES
    J Invasive Cardiol; 2019 Jan; 31(1):1-9. PubMed ID: 30611122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Common Femoral Artery Atherosclerotic Disease.
    Stavroulakis K; Schwindt A; Torsello G; Beropoulis E; Stachmann A; Hericks C; Bollenberg L; Bisdas T
    J Endovasc Ther; 2018 Feb; 25(1):92-99. PubMed ID: 29251204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical view of the peripheral atherectomy data in the treatment of infrainguinal arterial disease.
    Quevedo HC; Arain SA; Ali G; Abi Rafeh N
    J Invasive Cardiol; 2014 Jan; 26(1):22-9. PubMed ID: 24402808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of atherectomy in BTK lesions: a systematic review.
    Pitoulias AG; Pitoulias GA
    J Cardiovasc Surg (Torino); 2022 Feb; 63(1):20-24. PubMed ID: 34792313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute procedural outcomes of orbital atherectomy for the treatment of common femoral artery disease: Sub-analysis of the CONFIRM Registries.
    Lee MS; Heikali D; Mustapha J; Adams G; Mahmud E
    Vasc Med; 2017 Aug; 22(4):301-306. PubMed ID: 28548625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovascular management as first therapy for chronic total occlusion of the lower extremity arteries: comparison of balloon angioplasty, stenting, and directional atherectomy.
    Gallagher KA; Meltzer AJ; Ravin RA; Graham A; Shrikhande G; Connolly PH; Aiello F; Dayal R; McKinsey JF
    J Endovasc Ther; 2011 Oct; 18(5):624-37. PubMed ID: 21992631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE).
    Shammas NW; Shammas GA; Jones-Miller S; Shammas WJ; Bou-Dargham B; Shammas AN; Banerjee S; Rachwan RJ; Daher GE
    Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):771-777. PubMed ID: 30420096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries.
    Sixt S; Carpio Cancino OG; Treszl A; Beschorner U; Macharzina R; Rastan A; Krankenberg H; Neumann FJ; Zeller T
    J Vasc Surg; 2013 Sep; 58(3):682-6. PubMed ID: 23755977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Peripheral Arterial Disease Interventions on Survival: A Propensity-Score Matched Analysis Using VQI Data.
    Mukherjee D; Liu C; Jadali A; Lewis E; Neville R
    Ann Vasc Surg; 2022 Feb; 79():162-173. PubMed ID: 34644639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.